Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status

Por Šímová, J, Polláková, V, Indrová, M, Mikyšková, R, Bieblová, J, Štěpánek, I, Bubeník, J, Reiniš, M
Publicado em 2011